AU505355B2 - Sustained release formulation - Google Patents
Sustained release formulationInfo
- Publication number
- AU505355B2 AU505355B2 AU12049/76A AU1204976A AU505355B2 AU 505355 B2 AU505355 B2 AU 505355B2 AU 12049/76 A AU12049/76 A AU 12049/76A AU 1204976 A AU1204976 A AU 1204976A AU 505355 B2 AU505355 B2 AU 505355B2
- Authority
- AU
- Australia
- Prior art keywords
- sustained release
- release formulation
- formulation
- sustained
- release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000013268 sustained release Methods 0.000 title 1
- 239000012730 sustained-release form Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55910775A | 1975-03-17 | 1975-03-17 | |
| USUS559,107 | 1975-03-17 | ||
| US65800376A | 1976-02-13 | 1976-02-13 | |
| USUS658,003 | 1976-02-13 | ||
| KR7600645A KR800001387B1 (en) | 1975-03-17 | 1976-03-16 | Process for preparing sustained release formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU1204976A AU1204976A (en) | 1977-09-22 |
| AU505355B2 true AU505355B2 (en) | 1979-11-15 |
Family
ID=27348140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU12049/76A Expired AU505355B2 (en) | 1975-03-17 | 1976-03-16 | Sustained release formulation |
Country Status (21)
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ197543A (en) * | 1980-07-02 | 1984-12-14 | Commw Scient Ind Res Org | Controlled release compositions for inclusion in intraruminal devices |
| CH649215A5 (de) * | 1981-04-29 | 1985-05-15 | Hoffmann La Roche | Pharmazeutische praeparate. |
| CH652025A5 (de) * | 1981-09-14 | 1985-10-31 | Hoffmann La Roche | Pharmazeutisches praeparat. |
| US4421736A (en) * | 1982-05-20 | 1983-12-20 | Merrel Dow Pharmaceuticals Inc. | Sustained release diethylpropion compositions |
| CH666406A5 (de) * | 1984-02-29 | 1988-07-29 | Sandoz Ag | Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten. |
| GB2154874B (en) * | 1984-02-29 | 1987-11-04 | Sandoz Ltd | Bromoscriptine compositions |
| WO1985004100A1 (en) * | 1984-03-21 | 1985-09-26 | American Home Products Corporation | Sustained release pharmaceutical capsules |
| JPS6143108A (ja) * | 1984-08-03 | 1986-03-01 | Nippon Shinyaku Co Ltd | 医薬品製剤及びその製造法 |
| HU195729B (en) * | 1985-02-05 | 1988-07-28 | Sandoz Ag | Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides |
| GB8524135D0 (en) * | 1985-10-01 | 1985-11-06 | Sandoz Ltd | Darodipine compositions |
| HU197201B (en) * | 1985-10-01 | 1989-03-28 | Sandoz Ag | Process for producing oral pharmaceutical compositions of controlled solubility of the active components |
| US4786503A (en) * | 1987-04-06 | 1988-11-22 | Alza Corporation | Dosage form comprising parallel lamine |
| US4814178A (en) * | 1987-07-01 | 1989-03-21 | Sanford Bolton | Floating sustained release therapeutic compositions |
| US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| IE64128B1 (en) * | 1990-02-26 | 1995-07-12 | Byrne Rynne Holdings Ltd | A pharmaceutical composition |
| US5629016A (en) * | 1991-01-30 | 1997-05-13 | Glaxo Wellcome Inc. | Water-dispersible tablets |
| KR100190254B1 (ko) * | 1991-01-30 | 1999-06-01 | 레슬리 에드워즈 | 수-분산성 정제 |
| CA2107678A1 (en) * | 1991-04-08 | 1992-10-09 | Kouichi Nakamichi | Capsule |
| ES2124303T3 (es) * | 1992-03-25 | 1999-02-01 | Depomed Inc | Formas de dosificacion de farmacos orales de liberacion retardada a base de hidroxietilcelulosa. |
| US5698226A (en) * | 1993-07-13 | 1997-12-16 | Glaxo Wellcome Inc. | Water-dispersible tablets |
| CA2174777A1 (en) * | 1993-10-29 | 1995-05-04 | Keith Sugden | Gelatin capsule fill able to foam |
| AU692483B2 (en) * | 1993-10-29 | 1998-06-11 | R.P. Scherer Corporation | Gelatin capsule fill able to foam |
| US5888540A (en) * | 1993-10-29 | 1999-03-30 | Sugden; Keith | Pharmaceutical products |
| NZ287277A (en) * | 1994-05-13 | 1998-05-27 | Smithkline Beecham Corp | Oral preparation containing calcium source within a hydrophilic polymer matrix for increasing calcium absorption in the stomach |
| AU709413B2 (en) * | 1994-12-01 | 1999-08-26 | Amarin Development Ab | Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants |
| FR2820318B1 (fr) * | 2001-02-08 | 2005-12-23 | Ellipse Pharmaceuticals | Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu |
| FR2820319B3 (fr) * | 2001-02-08 | 2003-12-05 | Ellipse Pharmaceuticals | Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu |
| EP1245227A1 (en) * | 2001-03-31 | 2002-10-02 | Jagotec Ag | A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same |
| FR2874325B1 (fr) * | 2004-08-19 | 2006-10-20 | Sanofi Synthelabo | Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1059624B (de) * | 1954-11-11 | 1959-06-18 | Dr Knut Jacobus Sundman | Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form |
| JPS5512411B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1974-03-12 | 1980-04-02 | ||
| DE2439538C3 (de) * | 1974-08-17 | 1980-07-17 | Ludwig Heumann & Co Gmbh, 8500 Nuernberg | Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe |
-
1976
- 1976-03-05 CH CH277676A patent/CH630257A5/de not_active IP Right Cessation
- 1976-03-11 IE IE508/76A patent/IE43083B1/en unknown
- 1976-03-15 NZ NZ180321A patent/NZ180321A/xx unknown
- 1976-03-15 LU LU74558A patent/LU74558A1/xx unknown
- 1976-03-15 FR FR7607363A patent/FR2304354A1/fr active Granted
- 1976-03-15 GR GR50306A patent/GR60341B/el unknown
- 1976-03-15 MC MC761182A patent/MC1101A1/xx unknown
- 1976-03-16 JP JP51027758A patent/JPS51115910A/ja active Granted
- 1976-03-16 AT AT192276A patent/AT353415B/de not_active IP Right Cessation
- 1976-03-16 ES ES446075A patent/ES446075A1/es not_active Expired
- 1976-03-16 GB GB10482/76A patent/GB1546448A/en not_active Expired
- 1976-03-16 PT PT64907A patent/PT64907B/pt unknown
- 1976-03-16 DK DK113676A patent/DK148344C/da not_active IP Right Cessation
- 1976-03-16 AU AU12049/76A patent/AU505355B2/en not_active Expired
- 1976-03-16 DE DE19762611041 patent/DE2611041A1/de active Granted
- 1976-03-16 SE SE7603325A patent/SE433804B/xx not_active IP Right Cessation
- 1976-03-16 CA CA248,018A patent/CA1073358A/en not_active Expired
- 1976-03-16 DD DD191877A patent/DD124102A5/xx unknown
- 1976-03-17 AR AR262597A patent/AR222624A1/es active
- 1976-03-17 NL NLAANVRAGE7602776,A patent/NL190313C/xx not_active IP Right Cessation
- 1976-03-29 PH PH18224A patent/PH14927A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU505355B2 (en) | Sustained release formulation | |
| AU498744B2 (en) | Release agent | |
| AU508266B2 (en) | Controlled release preparations | |
| AU500958B2 (en) | Shoe-sole configuration | |
| AU497066B2 (en) | Photocoplymerizable composition | |
| AU1108376A (en) | Polyhemoglobin | |
| AU1006976A (en) | Inhilator | |
| AU1025376A (en) | Pourer-stopper | |
| AU1670276A (en) | Tetrahydro-isoquinolines | |
| AU1230276A (en) | Amidinoureas | |
| AU500738B2 (en) | Preparation | |
| AU497446B2 (en) | Composition | |
| AU501016B2 (en) | Propargyl-2 phenylamino-2-impazolines | |
| AU522089B2 (en) | N-acetylmuramyl-dorl-alanyl-dorl-isoglutamine | |
| CA1020668A (en) | Tritium-in-air monitor | |
| AU511364B2 (en) | Absorption-refrigerant composition | |
| AU1408076A (en) | Lysolipin Antibioties | |
| AU505910B2 (en) | Neamatocidal composition | |
| AU499529B2 (en) | Dihydromocimycin | |
| AU497193B2 (en) | Sprinkler | |
| AU497971B2 (en) | Aryl-di-thioureas | |
| ZA761305B (en) | Sustained release formulation | |
| AU498384B2 (en) | Anti-timor composition | |
| AU1612176A (en) | Fluoro-steroids | |
| AU497591B2 (en) | Bedcovering |